Recombinant Tick-Borne Encephalitis Virus gE C-end (296-414)

Unlock the power of precision with our Recombinant Tick-Borne Encephalitis Virus gE C-end (296-414), a meticulously crafted biochemical marvel that holds the key to unlocking groundbreaking discoveries. This recombinant protein, derived from the C-terminal region (amino acids 296-414) of the envelope glycoprotein (gE) of the Tick-Borne Encephalitis Virus, is a testament to the relentless pursuit of scientific excellence.

Tick-borne encephalitis (TBE) is a serious and potentially life-threatening viral infection transmitted by ticks, posing a significant public health concern across various regions. Understanding the structure and function of the viral envelope glycoprotein is crucial for developing effective diagnostic tools, therapeutic interventions, and vaccines to combat this formidable disease. Our Recombinant Tick-Borne Encephalitis Virus gE C-end (296-414) is a vital component in this endeavor, empowering researchers and scientists to unravel the complexities of the virus and pave the way for groundbreaking advancements.

Unparalleled Quality and Purity

Crafted with the utmost care and attention to detail, our Recombinant Tick-Borne Encephalitis Virus gE C-end (296-414) boasts an exceptional purity level, ensuring reliable and consistent results in your research. This high-quality recombinant protein is the product of meticulous purification processes, meticulously designed to eliminate impurities and deliver a product of uncompromising integrity.

The Ref # 54-BITP1924 and the absence of a CAS number further attest to the uniqueness and specialized nature of this recombinant protein, making it an indispensable tool for researchers delving into the intricacies of tick-borne encephalitis. With its well-defined characteristics and comprehensive technical documentation, our Recombinant Tick-Borne Encephalitis Virus gE C-end (296-414) empowers you to push the boundaries of scientific discovery.

Versatile Applications in Immunology and Beyond

This Recombinant Tick-Borne Encephalitis Virus gE C-end (296-414) is a versatile biochemical reagent that finds its niche in a wide range of applications, particularly in the field of immunology. Researchers can leverage this recombinant protein to develop advanced diagnostic assays, design targeted therapeutic strategies, and explore the fundamental mechanisms underlying the host-pathogen interactions in tick-borne encephalitis.

Beyond the realm of immunology, this recombinant protein may also prove invaluable in structural biology studies, shedding light on the intricate architecture of the viral envelope glycoprotein and its role in viral entry and pathogenesis. Furthermore, its potential applications extend to vaccine development, where it can serve as a critical component in the formulation of effective immunization strategies against tick-borne encephalitis.

Unwavering Commitment to Safety and Sustainability

At the core of our Recombinant Tick-Borne Encephalitis Virus gE C-end (296-414) is a steadfast commitment to safety and environmental responsibility. Classified as an irritant, this recombinant protein requires careful handling and storage to ensure the well-being of researchers and the integrity of the sample. We provide comprehensive safety guidelines and technical documentation to empower you to navigate the handling and storage of this compound with the utmost care.

By choosing our Recombinant Tick-Borne Encephalitis Virus gE C-end (296-414), you are not only investing in a superior-quality biochemical reagent but also aligning with our unwavering dedication to sustainable practices. We are committed to minimizing the environmental impact of our operations, ensuring that your research contributes to a greener, more responsible future.

Unlock the Potential of Your Research